N-Nitroso Edoxaban Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Edoxaban is used to prevent stroke and blood clots in patients with a certain heart rhythm problem (eg, nonvalvular atrial fibrillation). Edoxaban is also used to treat deep venous thrombosis, a condition in which harmful blood clots form in the blood vessels of the legs.N-Nitroso Edoxaban Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Edoxaban Impurity 1 chemically represented as 5-nitroso-4,5,6,7- tetrahydrothiazolo[5,4-c] pyridin-2-amine.Synchemia is the leading manufacturing and exporter of N-Nitroso Edoxaban Impurity 1 .We supply N-Nitroso Edoxaban Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143140 |
| CAS No | NA |
| Mol.F. | C17H21N5O2S |
| Mol.Wt. | 359.45 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143141 |
| CAS No | NA |
| Mol.F. | C17H19N5O3 |
| Mol.Wt. | 341.37 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143142 |
| CAS No | NA |
| Mol.F. | C17H19N5O3S |
| Mol.Wt. | 373.43 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143143 |
| CAS No | NA |
| Mol.F. | C29H27N7OS2 |
| Mol.Wt. | 553.70 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143144 |
| CAS No | NA |
| Mol.F. | C12H9N3O2S |
| Mol.Wt. | 259.28 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143145 |
| CAS No | NA |
| Mol.F. | C15H17N5O2S |
| Mol.Wt. | 331.39 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143146 |
| CAS No | NA |
| Mol.F. | C15H17N5O2S |
| Mol.Wt. | 331.39 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143147 |
| CAS No | NA |
| Mol.F. | C24H19N7OS2 |
| Mol.Wt. | 485.58 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143148 |
| CAS No | NA |
| Mol.F. | C26H29N7O4 |
| Mol.Wt. | 503.56 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143149 |
| CAS No | NA |
| Mol.F. | C25H27N7O3 |
| Mol.Wt. | 473.54 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143150 |
| CAS No | NA |
| Mol.F. | C25H27N7O4 |
| Mol.Wt. | 489.54 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143151 |
| CAS No | NA |
| Mol.F. | C5H6N2O2 |
| Mol.Wt. | 126.12 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143152 |
| CAS No | NA |
| Mol.F. | C12H14N2O |
| Mol.Wt. | 202.3 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0143153 |
| CAS No | NA |
| Mol.F. | C12H14N2O |
| Mol.Wt. | 202.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143154 |
| CAS No | NA |
| Mol.F. | C12H14N2O |
| Mol.Wt. | 202.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143155 |
| CAS No | NA |
| Mol.F. | C9H10N2O |
| Mol.Wt. | 162.2 g/mole |
| INV STATUS | In Stock |